Related by context. All words. (Click for frequent words.) 70 KRAS oncogene 68 cisplatin resistant 67 proliferative disorders 67 oncogenic transformation 67 genomic alterations 67 chromosomal rearrangement 67 metaplasia 67 pancreatic endocrine 66 NKX#.# 66 p# mutations 66 RRM1 66 lymphomas leukemias 66 ALK gene 66 mutated K ras 66 BRCA1 BRCA2 66 prostate carcinoma 66 spontaneously regress 65 Leydig cell 65 germline mutations 65 TMPRSS2 ERG fusion 65 matrix metalloproteinases 65 mammary duct 65 mucinous 65 TGFBR1 65 gene amplification 65 gastric carcinomas 65 γδ T cells 65 BRCA deficient 65 potent inducer 65 STK# [002] 65 constitutively expressed 65 synovial cells 64 monogenic 64 NEIL1 64 C. pneumoniae 64 mutated p# 64 PI3K AKT 64 radiosensitivity 64 liver metastasis 64 CEACAM1 64 malignant phenotype 64 bronchial epithelial cells 64 nodal metastasis 64 BRAF gene 64 epithelial tissues 64 FGFs 64 haematopoietic 64 malignant prostate 64 HER2 neu 64 TMEM#B 64 anti angiogenic agents 64 p# mutation 64 molecular abnormalities 64 peritoneal carcinomatosis 64 isoenzyme 64 CYP#D# gene 64 genetic aberrations 64 K ras mutations 64 PTPN# 64 OGG1 64 radiolabeled antibodies 63 Papillary 63 Fibroblast 63 COL#A# 63 PIK3CA 63 CDK4 63 hypermethylated 63 suppresses tumor 63 bronchoalveolar 63 granulosa cell 63 EGF receptors 63 hyperplastic 63 cytotoxic therapies 63 ERBB2 63 sarcomatoid 63 beta1 integrin 63 ERK signaling 63 antiangiogenesis 63 cytolytic 63 mtDNA mutations 63 mitogen activated protein kinases 63 stellate cells 63 colorectal tumor 63 LRP5 63 TRPV4 63 childhood leukemias 63 pleiotropic 63 metabolizing enzymes 63 promoter methylation 63 thyroid carcinoma 63 hamartomas 63 antimitotic 63 virulence genes 63 SETDB1 63 carcinoids 63 unmutated 63 NOTCH1 63 IGFBP2 63 AMACR 63 Pgp 62 Wnt signaling pathway 62 ALK inhibitors 62 metastatic lymph nodes 62 neoplasias 62 Topoisomerase II 62 osteosarcomas 62 BRAF protein 62 MEF2A 62 MMP# 62 multigenic 62 cyclin E 62 ligand induced 62 N. gonorrhoeae 62 intracellular bacteria 62 lytic 62 Li Fraumeni 62 lymphoid cells 62 ADAMTS# 62 chromosomal mutations 62 HER2 positive breast 62 osteogenic 62 prostate carcinomas 62 germline mutation 62 non coding RNA 62 myopathies 62 invasive lobular 62 epithelial barrier 62 Upregulation 62 MTHFR 62 leukemic stem cells 62 druggable targets 62 colorectal carcinoma 62 MMP9 62 CHD5 62 neuroendocrine carcinoma 62 motexafin gadolinium 62 clonogenic 62 HLA DQ2 62 Genetic variants 62 FGFR3 62 cytologically 62 HbF 62 trophoblasts 62 natriuretic peptides 62 TET2 62 Immunohistochemical staining 62 pre malignant lesions 62 Src kinase 62 Histologically 62 promoter hypermethylation 62 GIST tumors 62 anti CD3 62 transcriptional repressor 62 Myostatin 62 MSH2 62 secretory pathway 62 TP# gene 62 mediated inhibition 62 micronuclei 62 mTOR inhibitors 62 premalignant lesions 62 GISTs 62 isotypes 62 serous ovarian cancer 62 normal karyotype 62 GPI anchored 62 adenocarcinomas 62 antibody mediated 62 teratogens 62 antiangiogenic therapy 62 oncoprotein 62 somatic mutations 62 tumorigenicity 62 neovasculature 62 lung epithelial cells 62 biochemical abnormalities 62 molecularly targeted therapies 62 gefitinib Iressa 62 oesophageal adenocarcinoma 62 EGFR mutant 62 NFAT 62 PKC inhibitors 62 Smac mimetic 62 GSTP1 62 leiomyomas 62 MT1 MMP 62 gastric carcinoma 61 antisense inhibition 61 DNA methylation patterns 61 epigenetic modification 61 heparanase 61 myofibroblasts 61 breast endometrial 61 Id1 61 DNA methyltransferases 61 cathepsins 61 precancerous condition 61 sarcosine 61 renal cysts 61 transgene expression 61 PPARg 61 HepDirect prodrug 61 HER2 overexpression 61 GPx 61 alveolar epithelial cells 61 EML4 ALK 61 survivin expression 61 intracellular signal transduction 61 pancreatic islet 61 granzyme B 61 Epstein Barr virus EBV 61 multiply uncontrollably 61 mammary cells 61 sequence homology 61 N Myc 61 breast cancer subtypes 61 murine models 61 endobronchial 61 tumoral 61 leucocytes 61 selectively inhibited 61 CCL# 61 vimentin 61 glycolytic pathway 61 gene rearrangements 61 PARP inhibition 61 renal fibrosis 61 uPAR 61 hypothalamic pituitary 61 K ras gene 61 pancreatic lung 61 tumor subtypes 61 NF kappaB activation 61 immunoregulatory 61 MMP2 61 endothelial activation 61 GATA4 61 epithelial tumors 61 IDH1 mutations 61 lymphangiogenesis 61 MLH1 61 ALK mutations 61 SPECT CT imaging 61 p# activation 61 chimeric mice 61 NSCLC tumors 61 antiproliferative effects 61 gastroesophageal 61 metastatic neuroendocrine tumors 61 ZNF# 61 TEL AML1 61 HER2 positive cancers 61 kidney urologic 61 adenomatous polyp 61 ovarian endometrial 61 hepatic fibrosis 61 MAP kinase 61 RAS mutations 61 gastrointestinal stromal tumors GISTs 61 Mutational 61 upregulates 61 anti fibrotic 61 clinicopathological 61 DHFR 61 Leydig cells 61 SSc 61 distal colon 61 myofibroblast 61 FGF ligands 61 renal carcinoma 61 4E BP1 61 MYCN amplification 61 E. faecalis 61 MCF7 61 STAT4 61 malignant ovarian 61 C1q 61 monocytic 61 esophageal gastric 61 Bleomycin 61 ABCB1 61 Gleevec resistant 61 lymphoid tissue 61 TP# mutation 61 Aspergillus species 61 Lymph node 61 beta subunit 61 infectious prion proteins 61 amyloid plaque formation 61 gastric cardia 61 redox active 61 fibrin deposition 61 FUS1 61 transrectal ultrasound guided 61 colorectal adenocarcinoma 61 malignant tissue 61 haematologic 61 divide uncontrollably 61 synthases 61 infecting organism 61 hormone receptor negative 61 c myc gene 61 methylation markers 61 Flt3 61 eccrine 61 Oncogenic 61 lymphocytic 61 WT1 61 ARF1 61 chromosomal aberrations 61 tubule 61 TGF alpha 61 P cadherin 61 glycosylated 61 Entamoeba 61 nonvascular 61 somatostatin receptors 60 multifactorial disease 60 seminomas 60 miRNA expression 60 ERK1 2 60 hepatoma 60 prostate cancer CaP 60 Smad3 60 Activating mutations 60 neurofibromas 60 renal cell carcinomas 60 CD# expression [001] 60 squamous cell lung cancer 60 metalloproteinase 60 pancreatic ductal adenocarcinoma 60 Genetic mutations 60 immuno modulatory 60 immunohistochemical analysis 60 Adrenergic 60 overactivated 60 CD#c 60 aberrant methylation 60 periodontal tissues 60 Trichophyton rubrum 60 chemoprotective 60 B7 H4 60 embryonic tissues 60 DNA adducts 60 fibrosarcoma 60 mTOR signaling pathway 60 noncancerous cells 60 Artsimovitch 60 splice variants 60 neurite outgrowth 60 EBNA1 60 antisense RNA 60 chronic inflammations 60 potent stimulator 60 ERK pathway 60 trophoblast cells 60 localized prostate 60 malignant pancreatic 60 inhibiting tumor 60 pituitary adenomas 60 Skeletal muscle 60 CREBBP 60 chlamydial 60 Peutz Jeghers syndrome 60 pancreatic ductal 60 mammary cancers 60 apo E 60 Prognostic factors 60 peroxisomal 60 lobular carcinoma 60 inherited mutations 60 adipogenic 60 KRAS mutated 60 spontaneous regression 60 Epstein Barr Virus EBV 60 TMPRSS2 ERG 60 PCNSL 60 fibrogenesis 60 histopathologic examination 60 posttranslational modifications 60 HMGCR 60 squamous carcinoma 60 γ secretase 60 S6K 60 neuro protective 60 RNA polymerases 60 Colon polyps 60 replicase 60 multinucleated 60 abnormal proteins 60 SMN1 60 epigenetically 60 Immunohistochemical analysis 60 oral squamous cell 60 diagnostic biomarker 60 Ets2 60 LHRH receptor positive 60 PPARγ 60 cytokine signaling 60 Basal cell 60 pleiotropic effects 60 metalloproteinases 60 lysophosphatidic acid 60 ductal 60 ADAM# 60 radiosensitive 60 benign neoplasms 60 synaptogenesis 60 KIT mutations 60 AGTR1 60 adenomatous 60 EGFR pathway 60 MYH9 gene 60 PI3K signaling 60 CHD7 60 lymphoid organs 60 epigenetic alterations 60 melanocytic 60 potent inhibition 60 modifier genes 60 HER2 amplification 60 Treg cell 60 PTEN mutations 60 Estrogen receptor positive 60 potent antiproliferative 60 Nanobacteria 60 imatinib resistance 60 nonalcoholic steatohepatitis NASH 60 highly vascularized 60 oncoproteins 60 pulmonary metastases 60 EGFR receptor 60 BRAF V#E 60 chemoresistant 60 forkhead 60 PTEN gene 60 Shp2 60 extramedullary 60 branching morphogenesis 60 precursor lesions 60 Squamous 60 hematopoietic progenitors 60 acinar cells 60 HER2 expression 60 VEGF inhibitors 60 ANCA associated 60 pleural fluid 60 downregulate 60 TOP2A gene 60 CYP#B# 60 glioblastoma tumor 60 chemosensitivity 60 enteroviral 60 primary cilia 60 serine proteases 60 eIF 4E 60 Pim kinases 60 mesenteric 60 Stat1 60 TGF ß1 60 mevalonate 60 FLT3 60 colon carcinoma 60 mesothelial cells 60 inhibit viral replication 60 CB2 receptor 60 neoplastic transformation 60 oligomerization 60 xenograft models 60 hepatocellular carcinomas 60 KRAS mutant 60 Genetic mutation 60 TXNIP 60 podocyte 60 hypoxia induced 60 neuritic 60 urothelial carcinoma 60 cytostatic 60 malignant transformation 60 MIF protein 60 PARP1 60 prostatic tissue 60 adrenocortical 60 kinase gene 60 myoepithelial 60 papillary carcinoma 60 nonviral 60 mutated protein 60 colorectal carcinogenesis 60 neoplastic cells 60 metabolomic profiles 60 SCN1A 60 T#I [002] 60 osteoid 60 potent suppressor 60 Lyn kinase 60 missense mutations 60 colorectal gastric 60 HLA DRB1 60 EGF receptor 60 posttranslational modification 60 colorectal adenoma 60 hypercoagulable 60 somatostatin receptor 60 percutaneous biopsy 60 superoxide anion 60 ABL1 60 neural progenitor cells 60 NK1R 60 RKIP 60 tumor metastases 60 lymphatic vessel 60 lymphoproliferative disorders 60 pro angiogenic 59 EGFR mutation positive 59 ERK activation 59 amyloid deposition 59 xenobiotic 59 oncomodulin 59 susceptibility locus 59 microsatellite instability 59 tyrosine phosphorylation 59 leiomyoma 59 bronchoalveolar lavage 59 SMAD4 59 enzymatically active 59 HepG2 cells 59 lobular carcinomas 59 MDR1 59 thymidylate synthase TS 59 flavopiridol 59 VHL gene 59 peri implant 59 inverse agonist 59 additively 59 lymphovascular invasion 59 FGFR4 59 MiCK assay 59 Sertoli cell 59 Leukemias 59 MAPK pathway 59 thymidine kinase 59 synovial tissue 59 anaplastic 59 cathepsin K 59 NKG2D 59 myelomas 59 coagulation cascade 59 phenothiazines 59 Mitomycin C 59 node metastases 59 parthenolide 59 lymphatic tissue 59 preferentially bind 59 choroidal vasculopathy 59 potently inhibited 59 CYT# potent vascular disrupting 59 obligate intracellular 59 conventional chemotherapies 59 lysyl oxidase 59 nitrotyrosine 59 TLE3 59 causative genes 59 mutated KRAS 59 EBV infection 59 prognostic markers 59 small molecule activators 59 DLX5 59 axonal degeneration 59 incidentalomas 59 KLF4 59 eicosanoid 59 HDAC6 59 bacterial virulence 59 esophagogastric junction 59 synovial fibroblasts 59 TGF beta1 59 NKT cells 59 malignant lymphomas 59 Helicobacter 59 herpesviruses 59 peroxidation 59 breast carcinomas 59 apocrine 59 β1 59 bronchogenic carcinoma 59 LKB1 59 histologically proven 59 p# deficient 59 PECAM 1 59 substrate specificity 59 metabolic enzymes 59 glycopeptides 59 mycobacterial 59 molecular subtypes 59 histological subtype 59 aerodigestive tract 59 precancerous tissues 59 differential gene expression 59 anaplastic lymphoma kinase ALK 59 histologic subtype 59 Legg Calvé Perthes disease 59 neuroblastomas 59 T#M 59 genetic loci 59 Amino acid 59 micrometastasis 59 NF1 gene 59 nutlin 3a 59 exocrine glands 59 vascularisation 59 endostatin 59 hyperresponsiveness 59 JAK#/JAK# 59 fibrocytes 59 GLUT1 59 IFNg 59 JNK1 59 JAK2 enzyme 59 FDG PET imaging 59 nucleosides 59 papillary renal cell carcinoma 59 beta amyloid peptides 59 hyperplastic polyps 59 gene deletions 59 urothelial cancer 59 CFTR inhibitors 59 peroxisome 59 acinar 59 EGFR protein 59 microtubule targeting 59 neuroendocrine cancers 59 tissue microenvironment 59 adenylate cyclase 59 lymphoid tissues 59 druggable target 59 thymidylate synthase 59 susceptibility loci 59 Hurthle cell 59 UVB induced 59 PKCi 59 tumor histology 59 breast cancer metastasis 59 etiologic agent 59 beta3 59 effector molecules 59 Estrogen receptor 59 autophagic 59 beta adrenergic receptors 59 B7 H3 59 epididymal 59 Chronic pancreatitis 59 clade B 59 ABCG2 59 NS3 protease 59 calcific 59 neoplastic lesions 59 mononuclear 59 osteoblastic 59 microvessels 59 orthotopic 59 FGFR2 59 DNMT1 59 neoplastic 59 p# MAPK 59 gastric adenocarcinoma 59 cyclophilin D 59 miR #c 59 pulmonary metastasis 59 costimulation 59 serine protease 59 Endometrial 59 glial tumors 59 induced cytotoxicity 59 GBA mutations 59 vacuolar 59 mesenchymal cell 59 BRAF V#E mutation 59 prognostic biomarker 59 anti angiogenic drugs 59 biliary obstruction 59 serotonin uptake 59 Squamous cell 59 MGUS 59 hypericin 59 S. maltophilia 59 viral nucleic acids 59 cyto 59 brain lesions 59 castrate resistant 59 AT1R 59 dimeric 59 familial pancreatic cancer 59 atypical hyperplasia 59 chromosomal anomalies 59 provirus 59 acetylcholine receptor 59 poly ADP ribose polymerase 59 adrenal hormone 59 iPS derived 59 cryosurgery freezing 59 endocrine therapies 59 premalignant 59 gene locus 59 molecular determinants 59 atherogenesis 59 thyroglobulin 59 ploidy 59 ras gene 59 uPA 59 aT cell 59 maternally inherited 59 inhibiting COX 59 activating mutation 59 BMP4 59 histone deacetylases 59 vitamin D receptors 59 phosphorylated proteins 59 aneuploid 59 keratinocyte 59 #T# L1 59 DU# [002] 59 antiapoptotic 59 transthyretin 59 Prostatic 59 chemo resistant 59 fig. S4 59 serologic tests 59 EGFR blockers 59 detecting precancerous 59 astrocytic 59 malignant growths 59 nonmetastatic 59 sarcoid 59 immunotoxin 59 DGAT1 59 Microarray analysis 59 bone morphogenetic proteins 59 coreceptor 59 TNFa 59 perfusion abnormalities 59 Androgen receptor 59 Human Leukocyte Antigen 59 homocystinuria 59 inhibits VEGF 59 C EBP alpha 59 mutant proteins 59 cellular prion protein 59 myeloperoxidase 59 inflammatory cytokine 59 organogenesis 59 SNP rs# [001] 59 HSF1 59 mutant KRAS 59 dihydrofolate reductase 59 clefting 59 capillary endothelial cells 59 multidrug 59 bronchodilatory 59 transgenic rats 59 diagnose coronary artery 59 MAPK signaling pathway 59 chemo immunotherapy 59 lymph node biopsies 58 Benign breast 58 Clusterin 58 DNA rearrangements 58 potently inhibit 58 superantigens 58 skeletal myoblasts 58 induced sputum 58 HipA 58 E#F# 58 metastatic lesions 58 PALB2 58 tumor suppressor PTEN 58 Dopaminergic 58 C. albicans 58 HFE gene 58 P selectin 58 benign moles 58 KRAS mutation 58 Western blotting 58 rifamycins 58 prostate colon 58 polyps growths 58 mineralocorticoid 58 collagen degradation 58 TCF#L# gene 58 5 HT2A serotonin 58 LDL receptor 58 pancreatic prostate 58 phenotypic expression 58 idiopathic PAH 58 metalloprotease 58 Rb#/p# 58 micrometastases 58 SOCS2 58 TNFα 58 histocompatibility 58 trastuzumab resistant 58 carbohydrate antigens 58 neurofibrillary 58 malignant nodules 58 mitochondrial enzyme 58 lung metastasis 58 c MYC 58 potent inhibitors 58 Akt1 58 Human papillomavirus 58 Cdc7 58 proviral 58 intestinal mucosal 58 Li Fraumeni syndrome 58 proto oncogene 58 anti neoplastic 58 PGE2 58 bladder tumors 58 endometrioid 58 gastric mucosa 58 LTB4 58 A. fumigatus 58 prostate ovarian 58 tryptase 58 aggrecan 58 micro calcifications 58 hereditary predisposition 58 plexiform neurofibromas 58 heterozygote 58 imatinib Gleevec 58 motor neuron degeneration 58 inhibiting telomerase 58 metabolize cholesterol 58 nonmelanoma skin cancers 58 calcium hydroxyapatite 58 airway hyper responsiveness 58 lactate dehydrogenase 58 intercellular signaling 58 CYP #D# 58 metachronous 58 airway hyperresponsiveness 58 NPC1 58 osteoclast 58 IFN γ 58 tonsillar 58 Cathepsin B 58 insoluble plaques 58 transgenic mouse models 58 NFkB 58 excess glutamate 58 FDG-PET/CT 58 potentiating 58 cyclic AMP cAMP 58 NPM1 gene 58 perivascular 58 Cytotoxic 58 MMP inhibitors 58 schwannomas 58 tenascin C 58 neuro degenerative disorders 58 stratifying patients 58 MTHFR gene 58 nucleolar 58 ADPKD 58 malignant ascites 58 Elevated serum 58 C#Y 58 acyltransferase 58 SPINK1 58 mutant allele 58 BMPR2 58 ER alpha 58 antinuclear antibodies 58 interleukin IL -# 58 retinoid X 58 myeloproliferative 58 Smac mimic 58 bladder ovarian 58 antimetabolite 58 IL 1β 58 PDGFR 58 XL# inhibits 58 mGluR5 antagonist 58 radioimmunotherapy RIT 58 progesterone receptor PR 58 ALI ARDS 58 abzymes 58 GBM tumors 58 c KIT 58 spongiform encephalopathies 58 etiologic 58 EGFR tyrosine kinase inhibitors 58 MLL2 58 cypin 58 Notch1 58 NF kB pathway 58 neuroinflammation 58 haemolytic 58 HER signaling pathway 58 Smac mimetics 58 metastatic colorectal 58 cAMP signaling 58 Gleevec inhibits 58 ductal cancer 58 thiopurine 58 microRNA expression 58 BPH benign prostatic 58 IL #R 58 presymptomatic 58 FGF2 58 BCL2 58 enterococcal 58 adrenoceptor 58 LRAT 58 estrogen receptor beta 58 cruzi 58 cofactors 58 lung epithelium 58 hematopoietic cells 58 gene polymorphisms 58 allelic variants 58 ependymomas 58 multiplex assay 58 intronic 58 polynucleotides 58 peritoneal fluid 58 coding genes 58 obstructive coronary artery 58 genetic determinants 58 MALT lymphoma 58 Genetic variation 58 neovascularization 58 neuro endocrine 58 neuroblastoma tumors 58 pRb 58 osteoblast 58 IGF1R 58 leukemic cell 58 xenograft tumors 58 huntingtin gene 58 drug metabolizing enzymes 58 antitumor efficacy 58 IDH1 mutation 58 #S rRNA gene 58 tRNA synthetases 58 polyglutamine diseases 58 Stat5 58 ductal carcinomas 58 metastatic gastric 58 M1 muscarinic 58 thyroid nodule 58 microdeletion 58 MC4R gene 58 neovascularisation 58 protein tyrosine phosphatase 58 Heterozygous 58 hormone secreting 58 p#NTR 58 thyrotropin 58 experimental autoimmune encephalomyelitis 58 inhibits protein synthesis 58 methylation patterns 58 fluoroquinolone resistance 58 RAS RAF MEK 58 refractory Hodgkin 58 mesangial 58 Cyclin D1 58 fusion enhancers 58 susceptibility alleles 58 PrPSc 58 pAkt 58 FDG uptake 58 CDH1 58 Ras oncogene 58 antiangiogenic agents 58 erythropoietic 58 NMIBC 58 hepatotoxic 58 cell adhesion molecule 58 eotaxin 58 p# mitogen activated 58 extracapsular extension 58 CpG island 58 IGF IR 58 prodynorphin 58 fibrocystic 58 antiproliferative activity 58 tumor nodules 58 Barrett mucosa 58 intermediate filaments 58 HLA DR4 58 BRCA2 carriers 58 Carcinoid tumors 58 assay detects 58 hematopoietic progenitor cells 58 alkylating 58 glucokinase 58 selectively inhibiting 58 sphingolipid